Pliant Therapeutics, Inc. (PLRX)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Bernard Coulie
Employees:
90
260 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO, CA, 94080
650-481-6770
Are you looking for these stocks instead?
Pliant Therapeutics, Inc. discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|